Biosurgery Market By Product (Surgical Sealants & Adhesives, Hemostats, Wound Management, Tissue Grafts, Staples), By Application (Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, General Surgery, Plastic & Reconstructive Surgery), By End-User (Hospitals, Ambulatory Surgery Centers, Clinics), and By Region; Global Insights & Forecast (2023 ? 2030)

As per Intent Market Research, the Biosurgery Market was valued at USD 15.3 billion in 2024-e and will surpass USD 25.7 billion by 2030; growing at a CAGR of 9.0% during 2025 - 2030.

The biosurgery market is rapidly expanding due to advancements in surgical technologies and an increased focus on improving patient outcomes post-surgery. This market includes a wide range of products that enhance surgical procedures, reduce complications, and accelerate recovery. With the growing number of surgical procedures globally, particularly in areas such as orthopedics, cardiovascular, and neurosurgery, there is a heightened demand for effective biosurgical products, including hemostats, surgical sealants, and wound management solutions.

The market's growth is also being driven by an increasing preference for minimally invasive surgeries, where biosurgical products play a critical role in improving the precision and safety of procedures. Moreover, the rise in aging populations and chronic diseases, which often require surgery, is fueling the demand for biosurgical solutions. As new products continue to emerge, the biosurgery market is expected to experience significant advancements in terms of innovation, providing healthcare professionals with better tools to manage surgical challenges.

Surgical Sealants & Adhesives are the Largest Owing to Versatility and Effectiveness in Surgical Procedures

Surgical sealants and adhesives are the largest subsegment in the biosurgery market, owing to their versatility and effectiveness in various surgical procedures. These products are widely used to close surgical wounds, prevent leakage of bodily fluids, and provide support during tissue repair. Surgical sealants and adhesives are especially valuable in reducing the need for sutures or staples, which can be more invasive and time-consuming to apply.

The demand for these products has surged due to their ability to improve surgical outcomes by ensuring faster healing and reducing complications such as infections. Their use in areas like orthopedic, cardiovascular, and neurosurgery is particularly prominent, where they help to manage complex surgical environments. As advancements in biocompatible materials continue to improve, surgical sealants and adhesives will remain the largest and most critical product category in the biosurgery market.

Orthopedic Surgery is the Largest Owing to High Incidence of Bone and Joint Disorders

Orthopedic surgery is the largest application in the biosurgery market, driven by the high incidence of bone and joint disorders, particularly among the aging population. Procedures such as joint replacements, spinal surgeries, and fracture repairs often require the use of advanced biosurgical products like hemostats, tissue grafts, and surgical adhesives to manage bleeding, enhance wound healing, and promote tissue repair.

The demand for biosurgery products in orthopedic surgery continues to grow, supported by the increasing prevalence of musculoskeletal diseases such as osteoarthritis, as well as the rising number of sports injuries. With the continued focus on improving surgical outcomes and reducing recovery time, orthopedic surgery remains the largest application for biosurgery products, propelling market growth in this sector.

Hospitals are the Largest End-User Owing to High Surgical Volumes

Hospitals are the largest end-user segment in the biosurgery market, accounting for the highest demand for surgical products due to the sheer volume of procedures performed in these settings. Hospitals routinely perform a wide range of surgeries, including orthopedic, cardiovascular, and general surgeries, where biosurgical products such as hemostats, surgical sealants, and wound management solutions are essential to improving patient outcomes.

The growing number of surgical procedures, combined with the need for advanced medical solutions in hospital settings, ensures that hospitals will remain the dominant end-user in the biosurgery market. Additionally, hospitals often have the resources and infrastructure to invest in the latest biosurgical technologies, further solidifying their position as the largest end-user segment.

North America is Largest Owing to Advanced Healthcare Infrastructure and High Surgical Procedure Rates

North America is the largest region in the biosurgery market, owing to its advanced healthcare infrastructure and high surgical procedure rates. The United States, in particular, is a key market, with a high number of surgeries performed annually across various specialties, including orthopedic, cardiovascular, and general surgery. The region's healthcare system is also highly focused on adopting advanced technologies, which supports the widespread use of biosurgical products.

The rising demand for minimally invasive surgeries, coupled with an aging population that requires frequent surgical interventions, contributes to North America’s leadership in the global biosurgery market. With ongoing innovations in surgical products and a strong emphasis on improving patient outcomes, North America is expected to maintain its position as the largest region in this market.

Leading Companies and Competitive Landscape

The biosurgery market is highly competitive, with key players such as Johnson & Johnson, Medtronic, Baxter International, and Cryolife, Inc. leading the development and commercialization of advanced surgical products. These companies offer a wide range of biosurgical solutions, including surgical sealants, hemostats, wound management products, and tissue grafts, catering to the diverse needs of hospitals, ambulatory surgery centers, and clinics.

The competitive landscape is characterized by continuous innovation, with companies investing heavily in research and development to improve the performance and biocompatibility of their products. Additionally, strategic partnerships and acquisitions are common as companies seek to expand their product portfolios and strengthen their market presence. As the demand for advanced surgical solutions continues to rise, these leading companies will play a key role in shaping the future of the biosurgery market.

Recent Developments:

• In December 2024, Johnson & Johnson introduced a new surgical sealant designed for use in cardiovascular surgeries, promising quicker recovery times.
• In November 2024, Medtronic launched an advanced hemostat for orthopedic procedures, improving patient outcomes in bone surgeries.
• In October 2024, Stryker Corporation expanded its wound care portfolio with a new line of biosurgical products for use in plastic surgery.
• In September 2024, Baxter International partnered with several hospitals to test new biosurgery products for faster tissue healing.
• In August 2024, Integra LifeSciences received FDA approval for a novel tissue graft used in neurosurgery to repair spinal injuries.

List of Leading Companies:

• Johnson & Johnson
• Medtronic
• Baxter International
• Stryker Corporation
• B. Braun Melsungen AG
• Smith & Nephew
• Hill-Rom Holdings, Inc.
• Terumo Corporation
• Conmed Corporation
• Integra LifeSciences
• KCI Medical
• Mölnlycke Health Care
• CSL Behring
• Mylan N.V.
• Becton Dickinson and Company

Report Scope: